COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2196: Articles 21951-21960  | Next

BayesSMILES: Bayesian Segmentation Modeling for Longitudinal Epidemiological Studies
Jiang, S., Zhou, Q., Zhan, X., Li, Q.
10.1101/2020.10.06.20208132 — Posted: 2020-10-08
Suicide and mental health during the COVID-19 pandemic in Japan
Ueda, M., Nordström, R., Matsubayashi, T.
10.1101/2020.10.06.20207530 — Posted: 2020-10-08 Discussion: Onsite
Comparison of efficacy of Dexamethasone and Methylprednisolone in improving P/F ratio among COVID-19 patients
Rana, M. A., Hashmi, M. S., Qayyum, A., Pervaiz, R., Saleem, M., Munir, M. F., Ullah Saif, M. M.
10.1101/2020.10.06.20171579 — Posted: 2020-10-08
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
Aparisi, A., Iglesias-Echeverria, C., Ybarra-Falcon, C., Cusacovich, I., Uribarri, A., Garcia-Gomez, M., Ladron, R., Fuertes, R., Candela, J., Hinojosa, W., Duenas, C., Gonzalez, R., Nogales-Martin, L., Calvo, D., Carrasco-Moraleja, M., San Roman, J. A., Amat-Santos, I. J., Andaluz Ojeda, D.
10.1101/2020.10.06.20207092 — Posted: 2020-10-08
Real-World Effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: Results of a target trial emulation using observational data from a nationwide Healthcare System in Peru
Soto-Becerra, P., Culquichicon, C., Hurtado-Roca, Y., Araujo-Castillo, R. V.
10.1101/2020.10.06.20208066 — Posted: 2020-10-08 Discussion: Onsite
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19
Boonyaratanakornkit, J., Morishima, C., Selke, S., Zamora, D., McGuffin, S., Shapiro, A. E., Campbell, V. L., McClurkan, C. L., Jing, L., Gross, R., Liang, J., Postnikova, E., Mazur, S., Chaudhary, A., Das, M. K., Fink, S. L., Bryan, A., Greninger, A. L., Jerome, K. R., Holbrook, M. R., Gernsheimer, T. B., Wener, M. H., Wald, A., Koelle, D. M.
10.1101/2020.10.06.20207472 — Posted: 2020-10-08
Clinical and immunoserological status 12 weeks after infection with COVID-19: prospective observational study
Valiente-De Santis, L., Perez-Camacho, I., Sobrino, B., Gonzalez, G. E., Ruiz-Mesa, J. D., Plata, A., Marquez-Gomez, I., Cobos, L., Delgado-Fernandez, M., Castano, M., Onate, F., Orihuela, F., Palop, B., Reguera, J. M.
10.1101/2020.10.06.20206060 — Posted: 2020-10-08
System Dynamics Model of Possible Covid-19 Trajectories Under Various Non-Pharmaceutical Intervention Options in Low Resource Setting.
Kivuti-Bitok, L. W., Momodu, A. S., Jebet, J. C., Kimemia, F., Gichuki, I., Ngune, I.
10.1101/2020.10.06.20204487 — Posted: 2020-10-08
Personal protective equipment for reducing the risk of COVID-19 infection among healthcare workers involved in emergency trauma surgery during the pandemic: a systematic review protocol
Griswold, D., Gempeler, A., Kolias, A., Hutchinson, P. J., Rubiano, A. M.
10.1101/2020.09.26.20201954 — Posted: 2020-10-08
Age- and Sex-Specific Modelling of the COVID-19 Epidemic
Doerre, A., Doblhammer, G.
10.1101/2020.10.06.20207951 — Posted: 2020-10-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).